169240 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses; Bacteria Chlamydia
Sexually Transmitted Infection Testing from Human Dried Blood Spots Collected Remotely
#2DEVICES AND METHODS FOR TISSUE AND CELL STAINING (II)
#3Reliable and Scalable Methods of Detection and Platform for Consumer Medical Devices
#4Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications
#5METHODS AND DEVICES FOR DETECTION OF PATHOGENS
#6Vaccine composition against Chlamydiaceae infections
#7Devices and methods for tissue and cell staining (II)
#8Reliable, comprehensive, and rapid sexual health assessment
#9Vaccine composition against infections
#10CHLAMYDIA SUIS DIAGNOSIS
#11Diagnostic Method and System for Diagnosis
#12SINGLE-STEP ATPS ENHANCED LFA DIAGNOSTIC DESIGN
#13Reliable, comprehensive, and rapid sexual health assessment
#14Methods and devices for detection of pathogens
#15Chlamydia antigens
#16METHODS FOR ASSESSING THE POTENTIAL FOR REPRODUCTIVE SUCCESS AND INFORMING TREATMENT THEREFROM
#17Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications
#18Vaccine composition against Chlamydiaceae infections
#19CHLAMYDIA ANTIGENS
#20Method and peptides for the detection of
#21Transcriptional signature for chlamydial pelvic inflammatory disease
#22Compositions and methods for immunodominant antigens
#23Method of treatment of chlamydial infections with selected EGFR inhibitors
#24Compositions and methods for immunodominant antigens of
#25BROAD SPECTRUM ANTIBIOTIC ARYLOMYCIN ANALOGS
#26Chlamydia antigens
#27Methods and devices for integrating analyte extraction, concentration and detection
#28Biocoated piezoelectric biosensor platform for point-of-care diagnostic use
#29Methods and Compositions for Treatment of Chlamydial Infection and Related Diseases and Disorders
#30METHOD OF INTRACELLULAR INFECTIOUS AGENT DETECTION IN SPERM CELLS
#31CHLAMYDIA ANTIGEN COMPOSITIONS AND USES THEREOF
#32Biomarkers for detecting the presence of bacteria
#33Chlamydia antigens
#34Methods and compositions for chlamydial antigens as reagents for diagnosis of tubal factor infertility and chlamydial infection
#35Interferon-Gamma Response as a Diagnostic Test for Persistent Chlamydial Infections
#36CHLAMYDIA PNEUMONIAE ASSOCIATED CHRONIC INTRAOCULAR DISORDERS AND TREATMENT THEREOF
#37Compositions and methods for immunodominant antigens of
#38Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#39Chlamydia antigens
#40IP-10 BASED IMMUNOLOGICAL MONITORING
#41Vaccines against chlamydial infection
#42Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation
#43Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
#44ANTIGENIC POLYPEPTIDES OF CHLAMYDIA-RELATED BACTERIA FOR DIAGNOSIS AND VACCINE
#45Compositions and methods for immunodominant antigens of
#46Genus-wide chlamydial peptide vaccine antigens
#47Chlamydia Pneumoniae Associated Chronic Intraocular Disorders and Treatment Thereof
#48CHLAMYDIA ANTIGENS
#49Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#50Biochip, and method for the selective identification of infections
#51Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
#52Compositions and methods for immunodominant antigens
#53antigens
#54IP-10 based immunological monitoring
#55AUTOMATED DETERMINATION OF CHLAMYDIA INFECTION-FORMING UNITS
#56Compositions and methods for immunodominant antigens of
#57OMP antigen
#58ANTIBODIES FOR DETECTING MICROORGANISMS
#59COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#60Treatment and Diagnosis of Obligate Intracellular Pathogens
#61Methods for detection of chlamydia in samples
#62Chlamydia Antigens and Uses Thereof
#63Detection of Lipid Oxidising Abzymes in Samples
#64Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#65COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#66COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#67CHLAMYDIA PNEUMONIAE VACCINE AND METHODS FOR ADMINISTERING SUCH A VACCINE
#68flagellar protein antigen
#69PMP proteins, gene sequences and uses thereof
#70PMP proteins, gene sequences and uses thereof
#71Native analyte as a reference in lateral flow assays
#72Screening method
#73Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#74Detection, imaging, and depletion of intracellular pathogens
#75Chlamydia trachomatis antigens
#76Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof
#77Detection and quantification of intracellular pathogens
#78Anti-chlamydial antibodies and uses thereof
#79Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#80Compounds and methods for treatment and diagnosis of chlamydial infection
#81Methods and reagents for the treatment of multiple sclerosis
#82Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
#83Sample preparation for the detection of infectious agents
#84Compounds and methods for treatment and diagnosis of chlamydial infection
#85Chlamydia protein, gene sequence and uses thereof
#86Method of using physiological markers to estimate cardiovascular risk
#87antigens and corresponding DNA fragments and uses thereof